Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of AP-L1898 in advanced or metastatic non-small cell lung cancer with uncommon EGFR mutations
CTR20211347Phase 2Active
- Sponsor
- Junjing Bio
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of js111 in non-small cell lung cancer (NSCLC), sponsored by Junjing Bio. Started Jul 2021; status: active.
02
Drugs
js111
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20211347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211347.